Paraplatin and Anzemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paraplatin (carboplatin) and Anzemet (dolasetron mesylate). Common drug interactions include drug toxicity among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Paraplatin and Anzemet. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

On Jul, 20, 2026

78 people who take Paraplatin and Anzemet together, and have interactions are studied.

Paraplatin and Anzemet drug interactions.

What are the common drug interactions of Paraplatin and Anzemet, by gender? *:

female:

Drug toxicity
Dry throat
Erythema (redness of the skin)
Failure to thrive (inadequate weight gain and physical growth in children)
Folliculitis (infection of hair root)
Headache (pain in head)
Heart rate increased
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Lethargy (tiredness)

male:

Dyspnoea (difficult or laboured respiration)
Blood pressure decreased
Lacrimation increased
Loss of consciousness
Pain
Pallor
Pruritus (severe itching of the skin)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Agitation (state of anxiety or nervous excitement)
Apnoea (suspension of external breathing)

What are the common drug interactions of Paraplatin and Anzemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Alopecia (absence of hair from areas of the body)
Anxiety
Emotional distress
Pain
Psychological trauma

40-49:

Vomiting
Dyspnoea (difficult or laboured respiration)
Coma (state of unconsciousness lasting more than six hours)
Death unexplained
Hypersensitivity
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Alopecia (absence of hair from areas of the body)
Anxiety
Blood pressure decreased

50-59:

Pruritus (severe itching of the skin)
Psychological trauma
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Pyrexia (fever)
Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Tenderness (pain or discomfort when an affected area is touched)
Thrombocytopenia (decrease of platelets in blood)
Tricuspid valve incompetence (inefficient heart valve)
Weight increased

60+:

Dyspnoea (difficult or laboured respiration)
Alopecia (absence of hair from areas of the body)
Flushing (the warm, red condition of human skin)
Heart rate irregular
Hypotension (abnormally low blood pressure)
Malignant neoplasm progression (cancer tumour came back)
Oxygen saturation decreased
Pallor
Agitation (state of anxiety or nervous excitement)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 7 people, 8.97%
Breast Cancer Female: 7 people, 8.97%
Lung Cancer Stage Unspecified (Excl Metastatic Tumors To Lung): 6 people, 7.69%
Breast Cancer: 5 people, 6.41%
Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Paraplatin and Anzemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously